市場調査レポート

商品コード

1193237

消化器系健康市場：タイプ別、形態別、流通チャネル別：世界の機会分析および産業予測、2021-2031年

Digestive Health Market By Type, By Form, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: 2022年10月01日 | 発行: Allied Market Research

| ページ情報: 英文 310 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 6,090 954,668円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,630 1,039,318円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 10,500 1,645,980円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=156.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の消化器系健康市場は、2021年に387億8913万米ドル、2031年には902億567万米ドルに達し、2022年から2031年までのCAGRは8.8%を記録すると予測されています。

消化器系健康は、人々の主要な関心事の一つです。人の健康全般は、不健康な腸によって大きな影響を受けるため、それを避けるために、正常な消化機能を確保し、食事から最大限の利益を得るための栄養素が必要であり、これにはプロバイオティクスから消化酵素まで、幅広い製品が含まれます。これらは健康な身体機能を促進し、口から胃にかけての病原微生物の管理を助けます。さらに、プロバイオティクスのサプリメントは、適切な量を使用すると、消化プロセスを支援し、栄養吸収を向上させることができます。

米国生物工学情報センター（NCBI）によると、消化器系の疾患は、米国で年間6000万から7000万人が罹患していると推定され、大腸がんは米国人男性と女性の間で診断される第2位のがんタイプとなっています。このように、世界中で消化器系疾患の有病率が高まっており、これが消化器系健康製品の必要性をさらに高めています。

さらに、消化器系健康市場の成長は、製薬会社や栄養補助食品会社による製品の多くの進歩の導入、慢性消化器系疾患を治療するためのソリューションの需要の増加、および簡単にアクセスでき、コスト効率の高い製品やサプリメントの広い範囲の可用性によって促進されると予想されます。

さらに、「腸の健康は体重管理の鍵」という動向の高まりとともに、プレバイオティクスメーカーは、世界的に高まるプレバイオティクス需要に追いつこうと躍起になっています。研究者たちは、腸内で消化と栄養素の吸収を助ける腸内細菌が減量能力に影響を与えることを発見し、体重を気にする人々の間でプレバイオティクスに対する需要の増加につながり、市場成長を推進しています。

スポーツやフィットネス活動の不足、健康的な栄養への国民の関心の高まり、消化器系健康のためのプロバイオティクスへの消費者による投資の増加、機能性食品への好みの高まりのため、個人の間で消化器系の問題が増加し、新製品の発売とともに、市場成長を推進しています。一方、主要な市場参加者による研究開発イニシアチブの増加は、市場の成長のための有利な機会を提供します。

市場成長を促進するさまざまな要因がありますが、厳しい政府規制や製造プロセスに関連する高い開発コストなど、市場に影響を与えるいくつかの抑制要因もあります。例えば、2002年の公衆衛生安全保障およびバイオテロリズムへの準備と対応に関する法律（バイオテロ法）では、栄養補助食品会社はFDAに登録し、緊急時に会社に連絡するために十分な情報をFDAに提供することが義務付けられています。

概要
- 市場規模および予測
プレバイオティクス
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
プロバイオティクス
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
消化酵素
- 主要な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第5章消化器系健康市場：形態別

概要
- 市場規模および予測
カプセル
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
錠剤
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第6章消化器系健康市場：流通チャネル別

概要
- 市場規模・予測
ドラッグストア、小売薬局
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別
- ドラッグストア・薬局向け消化器系健康市場：タイプ別
  - 処方薬市場規模・予測：地域別
  - OTC市場規模推移・予測：地域別
オンラインプロバイダー
- 主な市場動向、成長要因、機会
- 市場規模および予測：地域別
- 市場分析：国別
その他
- 主な市場動向、成長要因、機会
- 市場規模・予測：地域別
- 市場分析：国別

第7章消化器系健康市場：地域別

概要
- 市場規模・予測
北米
- 主な動向と機会
- 北米市場規模・予測：タイプ別
- 北米市場規模・予測：形態別
- 北米市場規模・予測：流通チャネル別
  - 北米ドラッグストア・小売薬局の消化器系健康市場：タイプ別
- 北米市場規模・予測：国別
  - 米国
  - カナダ
  - メキシコ
欧州
- 主な動向と機会
- 欧州の市場規模・予測：タイプ別
- 欧州市場規模・予測：形態別
- 欧州市場規模・予測：流通チャネル別
  - 欧州ドラッグストア・小売薬局の消化器系健康市場：タイプ別
- 欧州市場規模・予測：国別
  - ドイツ
  - フランス
  - 英国
  - イタリア
  - スペイン
  - その他欧州
アジア太平洋地域
- 主な動向と機会
- アジア太平洋地域の市場規模・予測：タイプ別
- アジア太平洋地域の市場規模・予測：形態別
- アジア太平洋地域の市場規模・予測：流通チャネル別
  - アジア太平洋地域のドラッグストア・小売薬局の消化器系健康市場：タイプ別
- アジア太平洋地域の市場規模・予測：国別
  - 日本
  - 中国
  - オーストラリア
  - インド
  - 韓国
  - その他アジア太平洋地域
LAMEA
- 主な動向と機会
- LAMEAの市場規模・予測：タイプ別
- LAMEAの市場規模・予測：形態別
- LAMEAの市場規模・予測：流通チャネル別
  - LAMEAドラッグストア・小売薬局の消化器系健康市場：タイプ別
- LAMEAの市場規模・予測：国別
  - ブラジル
  - サウジアラビア
  - 南アフリカ
  - LAMEAの残りの地域

第8章企業情勢

イントロダクション
主要成功戦略
主要10社の製品マッピング
競合ダッシュボード
競合のヒートマップ
主な発展

第9章企業プロファイル

Bayer AG
GalaxoSmithKline PLC
Pfizer Inc.
Sanofi
Nestle SA
Herbalife Nutrition Ltd.
BASF SE
NOW Health Group Inc.
Amway Corporation
The Bountiful Company（Nature's Bounty）

図表

LIST OF TABLES

TABLE 1. GLOBAL DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 2. DIGESTIVE HEALTH MARKET, FOR PREBIOTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 3. DIGESTIVE HEALTH MARKET FOR PREBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 4. DIGESTIVE HEALTH MARKET, FOR PROBIOTICS, BY REGION, 2021-2031 ($MILLION)
TABLE 5. DIGESTIVE HEALTH MARKET FOR PROBIOTICS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 6. DIGESTIVE HEALTH MARKET, FOR DIGESTIVE ENZYMES, BY REGION, 2021-2031 ($MILLION)
TABLE 7. DIGESTIVE HEALTH MARKET FOR DIGESTIVE ENZYMES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 8. GLOBAL DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 9. DIGESTIVE HEALTH MARKET, FOR CAPSULE, BY REGION, 2021-2031 ($MILLION)
TABLE 10. DIGESTIVE HEALTH MARKET FOR CAPSULE, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 11. DIGESTIVE HEALTH MARKET, FOR TABLET, BY REGION, 2021-2031 ($MILLION)
TABLE 12. DIGESTIVE HEALTH MARKET FOR TABLET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 13. DIGESTIVE HEALTH MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. DIGESTIVE HEALTH MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 15. GLOBAL DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 16. DIGESTIVE HEALTH MARKET, FOR DRUG STORES AND RETAIL PHARMACIES, BY REGION, 2021-2031 ($MILLION)
TABLE 17. DIGESTIVE HEALTH MARKET FOR DRUG STORES AND RETAIL PHARMACIES, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 18. GLOBAL DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 19. DIGESTIVE HEALTH MARKET, FOR PRESCRIPTION, BY REGION, 2021-2031 ($MILLION)
TABLE 20. DIGESTIVE HEALTH MARKET, FOR OTC, BY REGION, 2021-2031 ($MILLION)
TABLE 21. DIGESTIVE HEALTH MARKET, FOR ONLINE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
TABLE 22. DIGESTIVE HEALTH MARKET FOR ONLINE PROVIDERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 23. DIGESTIVE HEALTH MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 24. DIGESTIVE HEALTH MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 25. DIGESTIVE HEALTH MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 26. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 27. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 28. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 29. NORTH AMERICA DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 30. NORTH AMERICA DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 31. U.S. DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 32. U.S. DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 33. U.S. DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 34. CANADA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 35. CANADA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 36. CANADA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 37. MEXICO DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 38. MEXICO DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 39. MEXICO DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 40. EUROPE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 41. EUROPE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 42. EUROPE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 43. EUROPE DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 44. EUROPE DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 45. GERMANY DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 46. GERMANY DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 47. GERMANY DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 48. FRANCE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 49. FRANCE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 50. FRANCE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 51. UK DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 52. UK DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 53. UK DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 54. ITALY DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 55. ITALY DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 56. ITALY DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 57. SPAIN DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 58. SPAIN DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 59. SPAIN DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 60. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 61. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 63. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 64. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 68. JAPAN DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 69. JAPAN DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 70. JAPAN DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 71. CHINA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 72. CHINA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 73. CHINA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 74. AUSTRALIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 75. AUSTRALIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 76. AUSTRALIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 77. INDIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 78. INDIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 79. INDIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 80. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 81. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 83. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 84. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 85. REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 86. LAMEA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 87. LAMEA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 88. LAMEA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 89. LAMEA DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 90. LAMEA DIGESTIVE HEALTH MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 91. BRAZIL DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 92. BRAZIL DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 93. BRAZIL DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 94. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 95. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 96. SAUDI ARABIA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 97. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 98. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 99. SOUTH AFRICA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 100. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY TYPE, 2021-2031 ($MILLION)
TABLE 101. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY FORM, 2021-2031 ($MILLION)
TABLE 102. REST OF LAMEA DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 ($MILLION)
TABLE 103.BAYER AG: COMPANY SNAPSHOT
TABLE 104.BAYER AG: OPERATING SEGMENTS
TABLE 105.BAYER AG: PRODUCT PORTFOLIO
TABLE 106.BAYER AG: NET SALES,
TABLE 107.BAYER AG: KEY STRATERGIES
TABLE 108.GALAXOSMITHKLINE PLC: COMPANY SNAPSHOT
TABLE 109.GALAXOSMITHKLINE PLC: OPERATING SEGMENTS
TABLE 110.GALAXOSMITHKLINE PLC: PRODUCT PORTFOLIO
TABLE 111.GALAXOSMITHKLINE PLC: NET SALES,
TABLE 112.GALAXOSMITHKLINE PLC: KEY STRATERGIES
TABLE 113.PFIZER INC.: COMPANY SNAPSHOT
TABLE 114.PFIZER INC.: OPERATING SEGMENTS
TABLE 115.PFIZER INC.: PRODUCT PORTFOLIO
TABLE 116.PFIZER INC.: NET SALES,
TABLE 117.PFIZER INC.: KEY STRATERGIES
TABLE 118.SANOFI: COMPANY SNAPSHOT
TABLE 119.SANOFI: OPERATING SEGMENTS
TABLE 120.SANOFI: PRODUCT PORTFOLIO
TABLE 121.SANOFI: NET SALES,
TABLE 122.SANOFI: KEY STRATERGIES
TABLE 123.NESTLE SA: COMPANY SNAPSHOT
TABLE 124.NESTLE SA: OPERATING SEGMENTS
TABLE 125.NESTLE SA: PRODUCT PORTFOLIO
TABLE 126.NESTLE SA: NET SALES,
TABLE 127.NESTLE SA: KEY STRATERGIES
TABLE 128.HERBALIFE NUTRITION LTD.: COMPANY SNAPSHOT
TABLE 129.HERBALIFE NUTRITION LTD.: OPERATING SEGMENTS
TABLE 130.HERBALIFE NUTRITION LTD.: PRODUCT PORTFOLIO
TABLE 131.HERBALIFE NUTRITION LTD.: NET SALES,
TABLE 132.HERBALIFE NUTRITION LTD.: KEY STRATERGIES
TABLE 133.BASF SE: COMPANY SNAPSHOT
TABLE 134.BASF SE: OPERATING SEGMENTS
TABLE 135.BASF SE: PRODUCT PORTFOLIO
TABLE 136.BASF SE: NET SALES,
TABLE 137.BASF SE: KEY STRATERGIES
TABLE 138.NOW HEALTH GROUP INC.: COMPANY SNAPSHOT
TABLE 139.NOW HEALTH GROUP INC.: OPERATING SEGMENTS
TABLE 140.NOW HEALTH GROUP INC.: PRODUCT PORTFOLIO
TABLE 141.NOW HEALTH GROUP INC.: NET SALES,
TABLE 142.NOW HEALTH GROUP INC.: KEY STRATERGIES
TABLE 143.AMWAY CORPORATION: COMPANY SNAPSHOT
TABLE 144.AMWAY CORPORATION: OPERATING SEGMENTS
TABLE 145.AMWAY CORPORATION: PRODUCT PORTFOLIO
TABLE 146.AMWAY CORPORATION: NET SALES,
TABLE 147.AMWAY CORPORATION: KEY STRATERGIES
TABLE 148.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): COMPANY SNAPSHOT
TABLE 149.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): OPERATING SEGMENTS
TABLE 150.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): PRODUCT PORTFOLIO
TABLE 151.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): NET SALES,
TABLE 152.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY): KEY STRATERGIES

LIST OF FIGURES

FIGURE 1.DIGESTIVE HEALTH MARKET SEGMENTATION
FIGURE 2.DIGESTIVE HEALTH MARKET,2021-2031
FIGURE 3.DIGESTIVE HEALTH MARKET,2021-2031
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.DIGESTIVE HEALTH MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.PATENT ANALYSIS BY COMPANY
FIGURE 13.PATENT ANALYSIS BY COUNTRY
FIGURE 14.DIGESTIVE HEALTH MARKET,BY TYPE,2021(%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF PREBIOTICS DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PROBIOTICS DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF DIGESTIVE ENZYMES DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 18.DIGESTIVE HEALTH MARKET,BY FORM,2021(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CAPSULE DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF TABLET DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF OTHERS DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 22.DIGESTIVE HEALTH MARKET,BY DISTRIBUTION CHANNEL,2021(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DRUG STORES AND RETAIL PHARMACIES DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF ONLINE PROVIDERS DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS DIGESTIVE HEALTH MARKET,2021-2031(%)
FIGURE 26.DIGESTIVE HEALTH MARKET BY REGION,2021
FIGURE 27.U.S. DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 28.CANADA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 29.MEXICO DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 30.GERMANY DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 31.FRANCE DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 32.UK DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 33.ITALY DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 34.SPAIN DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 35.REST OF EUROPE DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 36.JAPAN DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 37.CHINA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 38.AUSTRALIA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 39.INDIA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 40.SOUTH KOREA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 41.REST OF ASIA-PACIFIC DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 42.BRAZIL DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 43.SAUDI ARABIA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 44.SOUTH AFRICA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 45.REST OF LAMEA DIGESTIVE HEALTH MARKET,2021-2031($MILLION)
FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 49.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 50.COMPETITIVE DASHBOARD
FIGURE 51.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 52.BAYER AG.: NET SALES ,($MILLION)
FIGURE 53.GALAXOSMITHKLINE PLC.: NET SALES ,($MILLION)
FIGURE 54.PFIZER INC..: NET SALES ,($MILLION)
FIGURE 55.SANOFI.: NET SALES ,($MILLION)
FIGURE 56.NESTLE SA.: NET SALES ,($MILLION)
FIGURE 57.HERBALIFE NUTRITION LTD..: NET SALES ,($MILLION)
FIGURE 58.BASF SE.: NET SALES ,($MILLION)
FIGURE 59.NOW HEALTH GROUP INC..: NET SALES ,($MILLION)
FIGURE 60.AMWAY CORPORATION.: NET SALES ,($MILLION)
FIGURE 61.THE BOUNTIFUL COMPANY (NATURE'S BOUNTY).: NET SALES ,($MILLION)

Product Code: A31458

The global digestive health market was valued at $38,789.13 million in 2021, and is projected to reach $90,205.67 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.

Digestive health is one of the main concerns that everyone talks about every day. The overall health of a person can be greatly impacted by an unhealthy gut and thus, to avoid the same, the body needs nutrients to ensure normal digestive function and to maximize the benefits from their diet, which includes a wide range of products from probiotics to digestive enzymes. These promote healthy body function and assist in management of pathogenic microbes from the mouth to stomach. In addition, probiotics supplements assist in digestion process and enhance nutrient absorption when used in proper amount.

According to the National Center for Biotechnology Information (NCBI), gastrointestinal diseases affect an estimated 60 to 70 million people annually in America, with colorectal cancer as the 2nd leading cancer type diagnosed among American men and women. Thus, there is a growing prevalence of digestive diseases around the globe, which further propels the need for digestive health products.

Furthermore, growth of the digestive health market is anticipated to be facilitated by introduction of numerous advancements in products by the pharmaceutical and nutraceutical companies, increase in demand for solutions to treat chronic digestive diseases, and availability of wide range of products and supplements that are easily accessible and cost-effective.

Moreover, with growth in trend of "Gut Health-Key of Weight Management," prebiotics manufacturers are scrambling to keep up with the rising demand for prebiotics globally. Researchers discovered that the bacteria in the gut, which aid in digestion and absorption of nutrients in intestines, can affect capacity to lose weight, thus leading to rise in demand for prebiotics among weight conscious population and propelling the market growth.

Rse in digestive issues among individuals, owing to lack of sports and fitness activities, growing focus of the population on healthy nutrition, and rise in investments by consumers in probiotics for digestive health and rising preference for functional foods, along with new product launches, propel the market growth. Whereas, increase in R&D initiatives by key market players provide lucrative opportunities for growth of the market.

Although, there are various factors that propel the market growth, there are few restraints that affect the market including stringent government regulations and high development cost associated with the manufacturing process. For instance, the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (the Bioterrorism Act) requires dietary supplement companies to register with FDA and provide FDA with sufficient information to contact companies in an emergency.

The digestive health market is segmented on the basis of product, form, distribution channel, and region. By product, it is divided into prebiotics, probiotics, and digestive enzymes. On the basis of type, it is segmented into capsules, tablets, and others. By distribution channel, it is segmented into drug stores & retail pharmacies, online providers, and others (supermarkets/hypermarkets). The drug stores & retail pharmacies segment is further divided into prescription and OTC (over-the-counter). Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in this report include Amway Corporation, Bayer AG, BASF SE, GlaxoSmithKline PLC, Herbalife Nutrition Ltd., Nestle SA, NOW Health Group Inc., Pfizer Inc., Sanofi, and the Bountiful Company (Nature's Bounty).

Key Benefits For Stakeholders

This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the digestive health market analysis from 2021 to 2031 to identify the prevailing digestive health market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the digestive health market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global digestive health market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

Prebiotics
Probiotics
Digestive Enzymes

By Form

Capsule
Tablet
Others

By Distribution Channel

Drug Stores and Retail Pharmacies
- Type
- Prescription
- OTC
Online Providers
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest Of Europe
Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest Of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest Of LAMEA
Key Market Players
- Bayer AG
- GalaxoSmithKline PLC
- Pfizer Inc.
- Sanofi
- Nestle SA
- Herbalife Nutrition Ltd.
- BASF SE
- NOW Health Group Inc.
- Amway Corporation
- The Bountiful Company (Nature's Bounty)

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings
- 3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Patent Landscape

CHAPTER 4: DIGESTIVE HEALTH MARKET, BY TYPE

4.1 Overview
- 4.1.1 Market size and forecast
4.2 Prebiotics
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
4.3 Probiotics
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
4.4 Digestive Enzymes
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country

CHAPTER 5: DIGESTIVE HEALTH MARKET, BY FORM

5.1 Overview
- 5.1.1 Market size and forecast
5.2 Capsule
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
5.3 Tablet
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
5.4 Others
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country

CHAPTER 6: DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL

6.1 Overview
- 6.1.1 Market size and forecast
6.2 Drug Stores and Retail Pharmacies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.2.4 Drug Stores and Retail Pharmacies Digestive Health Market by Type
  - 6.2.4.1 Prescription Market size and forecast, by region
  - 6.2.4.2 OTC Market size and forecast, by region
6.3 Online Providers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country

CHAPTER 7: DIGESTIVE HEALTH MARKET, BY REGION

7.1 Overview
- 7.1.1 Market size and forecast
7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Type
- 7.2.3 North America Market size and forecast, by Form
- 7.2.4 North America Market size and forecast, by Distribution Channel
  - 7.2.4.1 North America Drug Stores and Retail Pharmacies Digestive Health Market by Type
- 7.2.5 North America Market size and forecast, by country
  - 7.2.5.1 U.S.
  - 7.2.5.1.1 Market size and forecast, by Type
  - 7.2.5.1.2 Market size and forecast, by Form
  - 7.2.5.1.3 Market size and forecast, by Distribution Channel
  - 7.2.5.2 Canada
  - 7.2.5.2.1 Market size and forecast, by Type
  - 7.2.5.2.2 Market size and forecast, by Form
  - 7.2.5.2.3 Market size and forecast, by Distribution Channel
  - 7.2.5.3 Mexico
  - 7.2.5.3.1 Market size and forecast, by Type
  - 7.2.5.3.2 Market size and forecast, by Form
  - 7.2.5.3.3 Market size and forecast, by Distribution Channel
7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Type
- 7.3.3 Europe Market size and forecast, by Form
- 7.3.4 Europe Market size and forecast, by Distribution Channel
  - 7.3.4.1 Europe Drug Stores and Retail Pharmacies Digestive Health Market by Type
- 7.3.5 Europe Market size and forecast, by country
  - 7.3.5.1 Germany
  - 7.3.5.1.1 Market size and forecast, by Type
  - 7.3.5.1.2 Market size and forecast, by Form
  - 7.3.5.1.3 Market size and forecast, by Distribution Channel
  - 7.3.5.2 France
  - 7.3.5.2.1 Market size and forecast, by Type
  - 7.3.5.2.2 Market size and forecast, by Form
  - 7.3.5.2.3 Market size and forecast, by Distribution Channel
  - 7.3.5.3 UK
  - 7.3.5.3.1 Market size and forecast, by Type
  - 7.3.5.3.2 Market size and forecast, by Form
  - 7.3.5.3.3 Market size and forecast, by Distribution Channel
  - 7.3.5.4 Italy
  - 7.3.5.4.1 Market size and forecast, by Type
  - 7.3.5.4.2 Market size and forecast, by Form
  - 7.3.5.4.3 Market size and forecast, by Distribution Channel
  - 7.3.5.5 Spain
  - 7.3.5.5.1 Market size and forecast, by Type
  - 7.3.5.5.2 Market size and forecast, by Form
  - 7.3.5.5.3 Market size and forecast, by Distribution Channel
  - 7.3.5.6 Rest of Europe
  - 7.3.5.6.1 Market size and forecast, by Type
  - 7.3.5.6.2 Market size and forecast, by Form
  - 7.3.5.6.3 Market size and forecast, by Distribution Channel
7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Form
- 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
  - 7.4.4.1 Asia-Pacific Drug Stores and Retail Pharmacies Digestive Health Market by Type
- 7.4.5 Asia-Pacific Market size and forecast, by country
  - 7.4.5.1 Japan
  - 7.4.5.1.1 Market size and forecast, by Type
  - 7.4.5.1.2 Market size and forecast, by Form
  - 7.4.5.1.3 Market size and forecast, by Distribution Channel
  - 7.4.5.2 China
  - 7.4.5.2.1 Market size and forecast, by Type
  - 7.4.5.2.2 Market size and forecast, by Form
  - 7.4.5.2.3 Market size and forecast, by Distribution Channel
  - 7.4.5.3 Australia
  - 7.4.5.3.1 Market size and forecast, by Type
  - 7.4.5.3.2 Market size and forecast, by Form
  - 7.4.5.3.3 Market size and forecast, by Distribution Channel
  - 7.4.5.4 India
  - 7.4.5.4.1 Market size and forecast, by Type
  - 7.4.5.4.2 Market size and forecast, by Form
  - 7.4.5.4.3 Market size and forecast, by Distribution Channel
  - 7.4.5.5 South Korea
  - 7.4.5.5.1 Market size and forecast, by Type
  - 7.4.5.5.2 Market size and forecast, by Form
  - 7.4.5.5.3 Market size and forecast, by Distribution Channel
  - 7.4.5.6 Rest of Asia-Pacific
  - 7.4.5.6.1 Market size and forecast, by Type
  - 7.4.5.6.2 Market size and forecast, by Form
  - 7.4.5.6.3 Market size and forecast, by Distribution Channel
7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Type
- 7.5.3 LAMEA Market size and forecast, by Form
- 7.5.4 LAMEA Market size and forecast, by Distribution Channel
  - 7.5.4.1 LAMEA Drug Stores and Retail Pharmacies Digestive Health Market by Type
- 7.5.5 LAMEA Market size and forecast, by country
  - 7.5.5.1 Brazil
  - 7.5.5.1.1 Market size and forecast, by Type
  - 7.5.5.1.2 Market size and forecast, by Form
  - 7.5.5.1.3 Market size and forecast, by Distribution Channel
  - 7.5.5.2 Saudi Arabia
  - 7.5.5.2.1 Market size and forecast, by Type
  - 7.5.5.2.2 Market size and forecast, by Form
  - 7.5.5.2.3 Market size and forecast, by Distribution Channel
  - 7.5.5.3 South Africa
  - 7.5.5.3.1 Market size and forecast, by Type
  - 7.5.5.3.2 Market size and forecast, by Form
  - 7.5.5.3.3 Market size and forecast, by Distribution Channel
  - 7.5.5.4 Rest of LAMEA
  - 7.5.5.4.1 Market size and forecast, by Type
  - 7.5.5.4.2 Market size and forecast, by Form
  - 7.5.5.4.3 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPANY LANDSCAPE

8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments

CHAPTER 9: COMPANY PROFILES

9.1 Bayer AG
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
9.2 GalaxoSmithKline PLC
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
9.3 Pfizer Inc.
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
9.4 Sanofi
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
9.5 Nestle SA
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
9.6 Herbalife Nutrition Ltd.
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
9.7 BASF SE
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
9.8 NOW Health Group Inc.
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
9.9 Amway Corporation
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
9.10 The Bountiful Company (Nature's Bounty)
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments

消化器系健康市場：タイプ別、形態別、流通チャネル別：世界の機会分析および産業予測、2021-2031年

Digestive Health Market By Type, By Form, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章消化器系健康市場：タイプ別

第5章消化器系健康市場：形態別

第6章消化器系健康市場：流通チャネル別

第7章消化器系健康市場：地域別

第8章企業情勢

第9章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: DIGESTIVE HEALTH MARKET, BY TYPE

CHAPTER 5: DIGESTIVE HEALTH MARKET, BY FORM

CHAPTER 6: DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 7: DIGESTIVE HEALTH MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

消化器系健康市場：タイプ別、形態別、流通チャネル別：世界の機会分析および産業予測、2021-2031年

Digestive Health Market By Type, By Form, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021-2031

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

第4章 消化器系健康市場：タイプ別

第5章 消化器系健康市場：形態別

第6章 消化器系健康市場： 流通チャネル別

第7章 消化器系健康市場：地域別

第8章 企業情勢

第9章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

Key Market Segments

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET OVERVIEW

CHAPTER 4: DIGESTIVE HEALTH MARKET, BY TYPE

CHAPTER 5: DIGESTIVE HEALTH MARKET, BY FORM

CHAPTER 6: DIGESTIVE HEALTH MARKET, BY DISTRIBUTION CHANNEL

CHAPTER 7: DIGESTIVE HEALTH MARKET, BY REGION

CHAPTER 8: COMPANY LANDSCAPE

CHAPTER 9: COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場の概要

第4章消化器系健康市場：タイプ別

第5章消化器系健康市場：形態別

第6章消化器系健康市場：流通チャネル別

第7章消化器系健康市場：地域別

第8章企業情勢

第9章企業プロファイル